Articles tagged with Dna Binding Domains
Researchers characterized the structure and function of a protein that regulates sugar and fat levels, finding it can work with an unexpected partner - itself. This partnership may drive the expression of different genes than its usual partner, offering new therapeutic targets for diseases like liver cancer and diabetes.
Frank Buchholz's ERC project DC-PGE aims to develop fully programmable DNA editing enzymes that minimize off-target effects and increase safety in gene therapy. The goal is to create a platform for efficient and accurate genome editing tools to treat various genetic disorders.
Researchers uncover new insights into protein signal transduction, revealing key details about GRB2 and SOS1's role in passing signals. They discovered differences in the domains' dynamics and binding affinities, providing a more detailed mechanism for liquid-liquid phase separation.
Researchers have identified two novel DOF family transcription factors that enhance wheat regeneration and genetic transformation. These findings provide new insights into the transcriptional regulatory network involved in boosting wheat regeneration, offering opportunities for improving crop improvement.
Researchers at Rice University have discovered a new way protein structures communicate with each other to regulate hormone activity. This finding could lead to improved therapies for breast cancer and other diseases.
The study shows that the CTD and OD domains of mtp53 R273H play key roles in mutant p53 GOF, pertaining to processes associated with DNA replication. The authors investigated the role of these domains in cell proliferation, DNA replication, and cell cycle progression in breast cancer cells.
Researchers found that overexpression of hPCL3S promotes proliferation, anchorage-independent growth, and migration in human LNCaP prostate cancer cells. Silencing of endogenous hPCL3S in DU145 and PC3 prostate cancer cells impairs these effects.
Researchers develop peptoid-coated DNA origami that maintains structural integrity and functionality in different physiological environments, enabling potential use in delivering anti-cancer drugs and proteins. The method involves designing peptoids to stabilize DNA origami, with the brush-type architecture achieving optimal protection.
Researchers at Washington University in St. Louis have discovered a mechanism by which plants regulate the hormone auxin, affecting growth and development. The sticky properties of Aux/IAA repressor proteins allow them to bind to DNA-binding domains, controlling transcription.
A new study reveals how LuxO, a key response regulator in Vibrio cholerae's quorum-sensing cascade, regulates the pathogenicity of the disease-causing bacterium. The researchers discovered an unusual inhibitory mechanism that permanently switches on LuxO, opening doors for potential therapeutic interventions.
Researchers have identified mutations in the STAT3 protein that can block its ability to act as a transcription factor, suggesting a basis for new cancer treatments. The discovery reinforces the importance of targeting transcription factors like STAT3 in fighting cancer.
Researchers at UMass Medical School have developed a new CRISPR/Cas9 technology that improves gene editing accuracy by nearly 100 fold. The system combines the CRISPR/Cas9 complex with a programmable DNA-binding domain to verify an additional genetic feature before cutting the genome, reducing off-target changes.
A new study reveals that viruses share common DNA replication mechanisms, with the SV40 T-ag protein facilitating DNA binding and assembly of complex proteins. This discovery sheds light on a complex process previously difficult to investigate in eukaryotes.
Researchers at The Wistar Institute successfully determined the three-dimensional structure of the p53 protein bound as a dimer to DNA, revealing new insights into its anti-cancer activity. The study's findings suggest that the interface between the two proteins in the dimer is crucial for proper functioning and binding to DNA.
A study by Nikola Pavletich and colleagues reveals that BRCA2 protein binds to damaged DNA, repairing it. This discovery sheds light on the mechanism of breast cancer development and opens new avenues for treatment strategies.